EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway

Qin Yin, Sen Wang, Jie Yang, Cunyu Fan, Yihan Yu, Juan Li, Feng Mei, Shiwei Zhang, Rengang Xi, Xiuyun Zhang iD

Journal of Pharmacy and Pharmacology · 2023

DOI: 10.1093/jpp/rgad045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Qin Yin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Hypertension, Pulmonary. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eighth Batch of Wuhan Young and Middle-aged Medical Backbone Talents Training Project in 2020, Traditional Chinese Medicine Research Project of Hubei Provincial Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Nobiletin is a flavonoid found in the peel of Citrus sinensis (oranges). The purpose of this study is to investigate whether Nobiletin can alleviate the monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) and explore the underlying mechanisms.

Methods

The PAH rat model was replicated by subcutaneous injection of MCT. Nobiletin (1, 5 and 10 mg/kg) was administered by gavage from day 1 to day 21. After 21 days of MCT injection, the mean pulmonary artery pressure, pulmonary vascular resistance, Fulton Index, pulmonary artery remodelling, blood routine parameters, liver and kidney functions was measured. The level of inflammatory cytokines and PI3K/Akt/STAT3 were detected by qPCR, ELISA and western blot, the proliferation of pulmonary artery smooth muscle cells (PASMCs) was evaluated by CCK-8. Key findings Nobiletin (10 mg/kg) inhibited the MCT-induced increase in mean pulmonary artery pressure and pulmonary vascular resistance, right ventricular hypertrophy and pulmonary artery remodelling in rats. Nobiletin decreased the levels of inflammatory cytokines and phosphorylation level of PI3K/Akt/STAT3 in lungs of MCT-treated rats. Nobiletin inhibited the proliferation and lowered the inflammatory cytokines level induced by PDGF-BB in PASMCs.

Conclusion

Nobiletin attenuates MCT-induced PAH, and the potential mechanism is to inhibit inflammation through PI3K/Akt/STAT3 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Arterial HypertensionHypertension, PulmonaryRatsAnimalsProto-Oncogene Proteins c-aktMonocrotalinePhosphatidylinositol 3-KinasesPulmonary ArteryCytokinesDisease Models, AnimalFlavones

Stichwörter der Autor:innen

NobiletinPI3K/Akt/STAT3 pathwayinflammationpulmonary arterial hypertension

Substanzen

Proto-Oncogene Proteins c-aktMonocrotalinePhosphatidylinositol 3-KinasesCytokinesnobiletinFlavones

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, Hubei, China.
  • Department of Forensic Medicine, Guangxi Medical University, Nanning, Guangxi, China.
  • The First Clinical College of Hubei University of Chinese Medicine, Wuhan, China.
  • Department of Pathology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, Hubei, China.
  • Department of Radiology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, Hubei, China.
  • Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China.

ORCID-Profile: Xiuyun Zhang

Förderung

  • Eighth Batch of Wuhan Young and Middle-aged Medical Backbone Talents Training Project in 2020
  • Traditional Chinese Medicine Research Project of Hubei Provincial Administration of Traditional Chinese Medicine

Zitieren

APA

Yin, Q., Wang, S., Yang, J., Fan, C., Yu, Y., Li, J., Mei, F., Zhang, S., Xi, R., & Zhang, X. (2023). Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad045

Vancouver

Yin Q, Wang S, Yang J, Fan C, Yu Y, Li J, et al. Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad045

BibTeX
@article{Yin2023,
  author = {Yin, Qin and Wang, Sen and Yang, Jie and Fan, Cunyu and Yu, Yihan and Li, Juan and Mei, Feng and Zhang, Shiwei and Xi, Rengang and Zhang, Xiuyun},
  title = {Nobiletin attenuates monocrotaline-induced pulmonary arterial hypertension through PI3K/Akt/STAT3 pathway},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  doi = {10.1093/jpp/rgad045}
}
Kostenlos starten →